LeadIQ logo
Learn more at LeadIQ.com

Insights

Prime Editing Technology Prime Medicine, Inc. pioneers Prime Editing technology, enabling precise genetic corrections with potential applications across a wide range of diseases, presenting sales opportunities in the biotechnology sector.

Financial Growth With recent financing rounds totaling $210 million, including a $55 million equity investment from Bristol Myers Squibb, Prime Medicine's financial health signals growth and investment potential, making them an attractive partner for collaborations and services.

Strategic Alliances Strategic agreements with key players like Bristol Myers Squibb and Juno Therapeutics Inc. demonstrate Prime Medicine's ability to secure partnerships, offering avenues for joint ventures, product licensing, and sales synergies.

Market Expansion Venturing into the development of multiple Prime edited therapies, such as ex vivo T-cell therapies, Prime Medicine is diversifying its product portfolio and expanding into new market segments, creating opportunities for product sales and distribution.

Focus on Specific Diseases Receiving targeted funding for cystic fibrosis research highlights Prime Medicine's dedication to addressing specific diseases, presenting tailored sales opportunities for pharmaceutical companies or foundations focused on similar disease areas.

Similar companies to Prime Medicine, Inc.

Prime Medicine, Inc. Tech Stack

Prime Medicine, Inc. uses 8 technology products and services including Power BI, Microsoft Word, Oracle, and more. Explore Prime Medicine, Inc.'s tech stack below.

  • Power BI
    Business Intelligence
  • Microsoft Word
    Editors
  • Oracle
    Enterprise
  • Red Hat
    Operating Systems
  • JSON
    Programming Languages
  • Smartsheet
    Project Management
  • E-Sign
    Sales Enablement
  • Yoast SEO
    Search Engines

Media & News

Prime Medicine, Inc.'s Email Address Formats

Prime Medicine, Inc. uses at least 1 format(s):
Prime Medicine, Inc. Email FormatsExamplePercentage
FLast@primemedicine.comJDoe@primemedicine.com
89%
First.Last@primemedicine.comJohn.Doe@primemedicine.com
10%
Last_First@primemedicine.comDoe_John@primemedicine.com
1%

Frequently Asked Questions

Where is Prime Medicine, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s main headquarters is located at 60 First St Cambridge, Massachusetts 02141 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is Prime Medicine, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Prime Medicine, Inc. is a publicly traded company; the company's stock symbol is PRME.

What is Prime Medicine, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s official website is primemedicine.com and has social profiles on LinkedIn.

How much revenue does Prime Medicine, Inc. generate?

Minus sign iconPlus sign icon
As of September 2024, Prime Medicine, Inc.'s annual revenue reached $35M.

What is Prime Medicine, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Prime Medicine, Inc. have currently?

Minus sign iconPlus sign icon
As of September 2024, Prime Medicine, Inc. has approximately 281 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Financial Officer: A. R.Chief Technical Officer: A. L.Chief Business Officer: R. B.. Explore Prime Medicine, Inc.'s employee directory with LeadIQ.

What industry does Prime Medicine, Inc. belong to?

Minus sign iconPlus sign icon
Prime Medicine, Inc. operates in the Biotechnology Research industry.

What technology does Prime Medicine, Inc. use?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s tech stack includes Power BIMicrosoft WordOracleRed HatJSONSmartsheetE-SignYoast SEO.

What is Prime Medicine, Inc.'s email format?

Minus sign iconPlus sign icon
Prime Medicine, Inc.'s email format typically follows the pattern of . Find more Prime Medicine, Inc. email formats with LeadIQ.

How much funding has Prime Medicine, Inc. raised to date?

Minus sign iconPlus sign icon
As of September 2024, Prime Medicine, Inc. has raised $15M in funding. The last funding round occurred on Jan 25, 2024 for $15M.

When was Prime Medicine, Inc. founded?

Minus sign iconPlus sign icon
Prime Medicine, Inc. was founded in 2019.
Prime Medicine, Inc.

Prime Medicine, Inc.

Biotechnology ResearchMassachusetts, United States201-500 Employees

Prime Medicine was founded to bring the promise of gene editing to patients. We use Prime Editing, a next-generation technology that can “search and replace” to restore normal genetic function almost anywhere in the genome. Prime Editing searches to find the precise place in the genome to edit and replaces the segment of faulty DNA with a correct copy of DNA.  A single Prime Editor can correct the individual mutations found across patients, meaning Prime Editing can potentially address more than 90 percent of known disease-causing genetic mutations.  

We envision a world where this technology can cure, halt, and ultimately prevent genetic diseases, providing lifelong benefit to patients.  Prime Medicine offers the opportunity to shape the future of gene editing and transform how medicines are used to treat disease. Realizing the promise of Prime Editing requires a talented team with diversity of viewpoints and expertise. We’re building a group of dedicated, scientifically curious individuals who are passionate about helping patients live longer, healthier lives.

Section iconCompany Overview

Headquarters
60 First St Cambridge, Massachusetts 02141 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PRME
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $15M

    Prime Medicine, Inc. has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2024 in the amount of $15M.

  • $10M$50M

    Prime Medicine, Inc.'s revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $15M

    Prime Medicine, Inc. has raised a total of $15M of funding over 3 rounds. Their latest funding round was raised on Jan 25, 2024 in the amount of $15M.

  • $10M$50M

    Prime Medicine, Inc.'s revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.